All participants in the Phase 3 clinical trial of Taiwan-based Medigen Vaccine Biologics Corp.'s COVID-19 vaccine in Paraguay have now received two shots of either the Medigen or AstraZeneca vaccine, the company said Monday.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Business
Taipower grid resilience plan to give science parks direct power supply
04/25/2024 08:58 PM - Business
President Tsai lauds inauguration of Changhua offshore wind farms
04/25/2024 08:38 PM - Society
Number of black-faced spoonbills in Taiwan falls for first time
04/25/2024 07:32 PM - Cross-Strait
New MAC head signals Lai's wish for stable cross-strait ties: Analysts
04/25/2024 07:06 PM - Society
5 executives at restaurants accused of using expired meat released on bail
04/25/2024 06:10 PM